About
R&D
Approach
Therapeutic areas
Scientific publications
R&D centers
Scientific and medical board
Scientific partnerships
Pipeline
Overview
TOTUM•63
TOTUM•070
TOTUM•854
TOTUM•448
Manufacturing
Investors
Presentation
Shareholder space
Financial Information
Breakdown of Share Capital
Financial Calendar
Regulatory information
Annual General Meeting
Newsroom
News
Releases
Media resources
FR
EN
European Association for the Study of Diabetes (EASD) Congress
Page d'accueil
>
European Association for the Study of Diabetes (EASD) Congress
Valbiotis presents its data on the multi-target mode of action of TOTUM•63, active principle of VALEDIA®, on October 4, 2018 (poster).